At times, our affiliate partners reach out to the Editors at Top Financial Cases with special opportunities for our readers. The message below is one we think you should take a close, serious look at.
3 Dividend Stocks to Buy and Hold Forever (for a lifetime of income)
I expect them to increase their dividend payouts in the years to come... so BUYING NOW means you could be picking up shares at an amazing price.
Get them at a discount: Dividend stocks are about to recover from the 2020 crash, meaning there's still time to get shares at a better price than most did in 2019.
Grow your income each month without lifting a finger: As these 3 stocks grow their dividends, you collect more income without investing more cash.
Give yourself more time and freedom: I believe you could buy and hold these 3 stocks forever. Meaning, no wild trading or timing the market.
P.S. When you go see these 3 stocks, I also have a bonus report to share with you, The 36-Month Accelerated Income Plan to Pay Your Bills for Life. This is my #1 strategy to turn a small $25k stake into an income stream that pays your bills each month. Go here to see this 2nd report.
A review of the clinical records of 44 patients who died under the care of the disgraced former neurologist Michael Watt has found a misdiagnosis rate of 45%. In 2018, more than 2,500 of Watt's neurology patients in Northern Ireland, including children, were recalled for a case review. An independent inquiry launched in 2018 found there were numerous failures, that opportunities were missed by the Belfast Health Trust to identify problems with the neurologist's practice and that earlier intervention by the trust would have "made a difference". In October last year, Watt was removed from the medical register after he made a voluntary application – meaning allegations about his work could not be heard in a tribunal by the General Medical Council (GMC). Advertisement Now, a review of 44 deceased cases, conducted by the Royal College of Physicians at the request of the regulator, the Regulation and Quality Improvement Authority (RQIA), has highlighted concerns over clinical decision-making, prescribing and diagnostics, the BBC reported. It reveals a misdiagnosis rate of 45% among the group of 44 patients. In several cases, a review of death certification, or referral to a medical examiner or coroner, was recommended, meaning coroners could be asked to reopen inquests. That could mean the reopening of some cases by the coroner if he is approached by families to do so. In a preface to the latest review, the RQIA's chair, Christine Collins, said: "Family accounts starkly illustrate how failings by the individual prac
You received this diansastroxz.forex@blogger.com as a result of your consent to receive 3rd party offers at our another website.
Email sent by Finance and Investing Traffic, LLC, owner and operator of Top Financial Cases.
To ensure you receive our emails to your inbox, be sure to whitelist us.
Post a Comment
Post a Comment